市場調査レポート

商品コード

アルツハイマー病治療薬市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Alzheimer's Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: 2023年06月14日 | 発行: IMARC

| ページ情報: 英文 144 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel (Single User License)

USD 2,499 392,692円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,499 549,832円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,499 706,972円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のアルツハイマー病治療薬の市場規模は2022年に72億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて6.11%の成長率（CAGR）を示し、2028年までに104億米ドルに達すると予測しています。

アルツハイマー病は、脳のいくつかの領域における神経細胞の変性を特徴とする疾患です。記憶、言語、思考、行動などの認知機能の喪失を引き起こします。アルツハイマーの一般的な症状には、抑うつ、記憶障害、抑制力の低下、思考や推論の問題などがあります。通常、身体検査、血液検査、脳画像検査、精神状態検査、神経心理学的検査を行うことで診断されます。その結果に応じて、医師は症状を緩和するためにさまざまな薬を処方します。アルツハイマー病治療薬は、脳の神経細胞間のメッセージ伝達に関与する化学物質である神経伝達物質の機能に影響を与えます。

アルツハイマー病治療薬の市場動向：

糖尿病、肥満、心臓病、高血圧は、座りがちなライフスタイル、不健康な食事パターン、喫煙と相まって、アルツハイマー病を発症する可能性を高める要因として知られています。高齢者人口の増加と相まって、大衆の間でこれらの疾患の有病率やライフスタイルの選択肢が増加していることは、市場の成長を促進する重要な要因の1つです。さらに、大手製薬企業は、病気を予防し、認知機能を長期にわたって改善する薬の開発に注力しています。市場の成長は、遠隔医療サービスの拡大やオンライン薬局の普及によってさらに支えられています。これらのプラットフォームにより、遠隔地での疾病診断やドラッグデリバリーが可能になっています。これとは別に、現在、Aducanumab、Solanezumab、Insulinなど、さまざまなアルツハイマー病治療薬が後期臨床試験段階にあります。

本レポートで扱う主な質問

世界のアルツハイマー病治療薬市場はこれまでどのように推移してきたか？
COVID-19が世界のアルツハイマー病治療薬市場に与えた影響は？
主要な地域市場は？
薬剤クラスに基づく市場内訳は？
販売チャネル別の市場内訳は？
業界のバリューチェーンにおける様々な段階とは？
業界の主要な促進要因と課題は何か？
世界のアルツハイマー病治療薬市場の構造と主要プレイヤーは？
業界の競合の程度は？

北米
- 米国
  - 市場動向
  - 市場予測
- カナダ
  - 市場動向
  - 市場予測
アジア太平洋
- 中国
  - 市場動向
  - 市場予測
- 日本
  - 市場動向
  - 市場予測
- インド
  - 市場動向
  - 市場予測
- 韓国
  - 市場動向
  - 市場予測
- オーストラリア
  - 市場動向
  - 市場予測
- インドネシア
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
欧州
- ドイツ
  - 市場動向
  - 市場予測
- フランス
  - 市場動向
  - 市場予測
- 英国
  - 市場動向
  - 市場予測
- イタリア
  - 市場動向
  - 市場予測
- スペイン
  - 市場動向
  - 市場予測
- ロシア
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
ラテンアメリカ
- ブラジル
  - 市場動向
  - 市場予測
- メキシコ
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
中東・アフリカ地域
- 市場動向
- 市場内訳：国別
- 市場予測

第9章 SWOT分析

概要
強み
弱み
機会
脅威

第10章バリューチェーン分析

第11章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第12章価格分析

第13章競合情勢

市場構造
主要プレーヤー
主要プレーヤーのプロファイル
- Abbvie Inc.
- AstraZeneca PLC
- Biogen Inc.
- Daiichi Sankyo Company Limited
- Eisai Co. Ltd.
- Eli Lilly and Company
- H. Lundbeck A/S
- F. Hoffmann-La Roche AG
- Merck & Co. Inc.
- Novartis AG
- Ono Pharmaceutical Co. Ltd.
- Pfizer Inc.
- Teva Pharmaceutical Industries Limited

図表

List of Figures

Figure 1: Global: Alzheimer's Drugs Market: Major Drivers and Challenges
Figure 2: Global: Alzheimer's Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Alzheimer's Drugs Market: Breakup by Drug Class (in %), 2022
Figure 4: Global: Alzheimer's Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 5: Global: Alzheimer's Drugs Market: Breakup by Region (in %), 2022
Figure 6: Global: Alzheimer's Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 7: Global: Alzheimer's Drugs (Donepezil) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Alzheimer's Drugs (Donepezil) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Alzheimer's Drugs (Galantamine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Alzheimer's Drugs (Galantamine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Alzheimer's Drugs (Rivastigmine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Alzheimer's Drugs (Rivastigmine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Alzheimer's Drugs (Memantine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Alzheimer's Drugs (Memantine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Alzheimer's Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Alzheimer's Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Alzheimer's Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Alzheimer's Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Alzheimer's Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Alzheimer's Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Alzheimer's Drugs (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Alzheimer's Drugs (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Alzheimer's Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Alzheimer's Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: North America: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: North America: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: United States: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: United States: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Canada: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Canada: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Asia Pacific: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Asia Pacific: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: China: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: China: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Japan: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Japan: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: India: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: India: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: South Korea: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: South Korea: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Australia: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Australia: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Indonesia: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Indonesia: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Others: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Others: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Europe: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Europe: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Germany: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Germany: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: France: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: France: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: United Kingdom: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: United Kingdom: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Italy: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Italy: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Spain: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Spain: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Russia: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Russia: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Others: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Others: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Latin America: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Latin America: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Brazil: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Brazil: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Mexico: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Mexico: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Others: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Others: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Middle East and Africa: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Middle East and Africa: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Global: Alzheimer's Drugs Industry: SWOT Analysis
Figure 74: Global: Alzheimer's Drugs Industry: Value Chain Analysis
Figure 75: Global: Alzheimer's Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Alzheimer's Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Alzheimer's Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 3: Global: Alzheimer's Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 4: Global: Alzheimer's Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Alzheimer's Drugs Market: Competitive Structure
Table 6: Global: Alzheimer's Drugs Market: Key Players

Product Code: SR112023A2695

The global alzheimer's drugs market size reached US$ 7.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.11% during 2023-2028.

Alzheimer's is a disease characterized by the degeneration of nerve cells in several areas of the brain. It causes loss of cognitive function, such as memory, language, thinking and behavior. The common symptoms of Alzheimer's include depression, memory impairment, loss of inhibitions, and problems with thinking and reasoning. It is usually diagnosed by performing physical exams, blood tests, brain imaging, and mental status and neuropsychological testing. According to the results, doctors prescribe different medications to alleviate symptoms. Alzheimer's drugs influence the functions of neurotransmitters, the chemicals involved in carrying messages between nerve cells in the brain.

Alzheimer's Drugs Market Trends:

Diabetes, obesity, heart diseases and high blood pressure (BP), in confluence with sedentary lifestyles, unhealthy dietary patterns and smoking, are some of the factors known to increase the chances of developing Alzheimer's disease. An increase in the prevalence of these ailments and lifestyle choices among the masses, coupled with the rising geriatric population, represents one of the key factors driving the market growth. Furthermore, the leading pharmaceutical companies are focusing on the development of drugs that prevent the disease and provide long-lasting improvements in cognitive functions. The market growth is further supported by the expansion of telehealth services and the growing traction of online pharmacies. These platforms have enabled disease diagnosis and drug delivery in remote regions. Apart from this, various Alzheimer's drugs are presently under late-stage clinical trials, including Aducanumab, Solanezumab and Insulin.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global alzheimer's drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class and distribution channel.

Breakup by Drug Class:

Donepezil

Galantamine

Rivastigmine

Memantine

Others

Breakup by Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Stores

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbvie Inc., AstraZeneca PLC, Biogen Inc., Daiichi Sankyo Company Limited, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Eli Lilly and Company, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Ono Pharmaceutical Co. Ltd., Pfizer Inc and Teva Pharmaceutical Industries Limited.

Key Questions Answered in This Report:

How has the global alzheimer's drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global alzheimer's drugs market?
What are the key regional markets?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global alzheimer's drugs market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Alzheimer's Drugs Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Drug Class

6.1 Donepezil
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Galantamine
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Rivastigmine
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Memantine
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Distribution Channel

7.1 Hospital Pharmacy
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Retail Pharmacy
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Online Stores
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 SWOT Analysis

9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 Abbvie Inc.
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 Financials
  - 13.3.1.4 SWOT Analysis
- 13.3.2 AstraZeneca PLC
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
  - 13.3.2.3 Financials
  - 13.3.2.4 SWOT Analysis
- 13.3.3 Biogen Inc.
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
  - 13.3.3.3 Financials
  - 13.3.3.4 SWOT Analysis
- 13.3.4 Daiichi Sankyo Company Limited
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
  - 13.3.4.3 Financials
  - 13.3.4.4 SWOT Analysis
- 13.3.5 Eisai Co. Ltd.
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
  - 13.3.5.3 Financials
  - 13.3.5.4 SWOT Analysis
- 13.3.6 Eli Lilly and Company
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio
  - 13.3.6.3 Financials
  - 13.3.6.4 SWOT Analysis
- 13.3.7 H. Lundbeck A/S
  - 13.3.7.1 Company Overview
  - 13.3.7.2 Product Portfolio
  - 13.3.7.3 Financials
  - 13.3.7.4 SWOT Analysis
- 13.3.8 F. Hoffmann-La Roche AG
  - 13.3.8.1 Company Overview
  - 13.3.8.2 Product Portfolio
  - 13.3.8.3 SWOT Analysis
- 13.3.9 Merck & Co. Inc.
  - 13.3.9.1 Company Overview
  - 13.3.9.2 Product Portfolio
  - 13.3.9.3 Financials
  - 13.3.9.4 SWOT Analysis
- 13.3.10 Novartis AG
  - 13.3.10.1 Company Overview
  - 13.3.10.2 Product Portfolio
  - 13.3.10.3 Financials
  - 13.3.10.4 SWOT Analysis
- 13.3.11 Ono Pharmaceutical Co. Ltd.
  - 13.3.11.1 Company Overview
  - 13.3.11.2 Product Portfolio
  - 13.3.11.3 Financials
  - 13.3.11.4 SWOT Analysis
- 13.3.12 Pfizer Inc.
  - 13.3.12.1 Company Overview
  - 13.3.12.2 Product Portfolio
  - 13.3.12.3 Financials
  - 13.3.12.4 SWOT Analysis
- 13.3.13 Teva Pharmaceutical Industries Limited
  - 13.3.13.1 Company Overview
  - 13.3.13.2 Product Portfolio
  - 13.3.13.3 Financials
  - 13.3.13.4 SWOT Analysis

アルツハイマー病治療薬市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Alzheimer's Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

アルツハイマー病治療薬の市場動向：

本レポートで扱う主な質問

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 アルツハイマー病治療薬の世界市場

第6章 市場内訳：薬剤クラス別

第7章 市場内訳：流通チャネル別

第8章 市場内訳：地域別

第9章 SWOT分析

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

第12章 価格分析

第13章 競合情勢

List of Figures

List of Tables

Alzheimer's Drugs Market Trends:

Key Market Segmentation:

Breakup by Drug Class:

Breakup by Distribution Channel:

Breakup by Region:

Competitive Landscape:

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Alzheimer's Drugs Market

6 Market Breakup by Drug Class

7 Market Breakup by Distribution Channel

8 Market Breakup by Region

9 SWOT Analysis

10 Value Chain Analysis

11 Porters Five Forces Analysis

12 Price Analysis

13 Competitive Landscape

第1章序文

第2章調査範囲と調査手法

第3章エグゼクティブサマリー

第4章イントロダクション

第5章アルツハイマー病治療薬の世界市場

第6章市場内訳：薬剤クラス別

第7章市場内訳：流通チャネル別

第8章市場内訳：地域別

第10章バリューチェーン分析

第11章ポーターのファイブフォース分析

第12章価格分析

第13章競合情勢